Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21)

The summary for the Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21): Purpose. This Funding Opportunity Announcement (FOA) is issued by the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Child Health and Human Development (NICHD), and the Fogarty International Center (FIC). The Fogarty International Center will accept only secondary assignments for potential co-funding with an Institute designated as primary assignee. The aim of this FOA is to invite applications for collaborations for exploratory and developmental work on HIV/AIDS in the low and middle income countries of the Middle East and North Africa (MENA), as defined by the World Bank: Algeria, Djibouti, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Oman, Syria, Tunisia, West Bank and Gaza, and Yemen. Specific areas of research include, but aren't limited to, epidemiologic studies, prevention research from both biomedical and social/behavioral perspectives, studies of social factors affecting the spread of HIV in the region, and research on women and youth. Collaborations must involve U.S. investigators from a partnering U.S. organization and one or more research teams in the MENA region. The collaborative effort supported through the R21 should help foster the development of HIV-relevant research infrastructure and expertise in the region and have the potential to lead to further research and improvements in public health.
Federal Grant Title: Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-08-153
Type of Funding: Grant
CFDA Numbers: 93.242
CFDA Descriptions: Mental Health Research Grants
Current Application Deadline: May 07, 2011
Original Application Deadline: May 07, 2011
Posted Date: May 09, 2008
Creation Date: Dec 05, 2008
Archive Date: Jun 07, 2011
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Li...
Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Inco...
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (...
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)
Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U...
Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com